What is the appropriate acne treatment plan for a patient using the Nexplanon (etonogestrel) contraceptive implant who cannot tolerate spironolactone?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Treatment Approach for Nexplanon-Associated Acne Without Spironolactone

Start with combination topical therapy using a topical retinoid plus benzoyl peroxide as your first-line treatment, and if this fails after 8-12 weeks or if acne is moderate-to-severe at presentation, proceed directly to isotretinoin rather than oral antibiotics. 1

Algorithmic Treatment Strategy

Step 1: Initiate Multimodal Topical Therapy

The 2024 AAD guidelines strongly recommend combining multiple mechanisms of action when treating acne topically 1:

  • Primary regimen: Fixed-dose combination topical retinoid with benzoyl peroxide (strong recommendation, moderate evidence) 1

    • Examples: adapalene 0.3% + benzoyl peroxide 2.5% gel
    • This addresses both comedonal and inflammatory lesions while preventing antibiotic resistance
  • Alternative if needed: Add topical clascoterone cream (conditional recommendation, high evidence) 1

    • This is a topical anti-androgen that directly blocks androgen receptors in the skin
    • Particularly relevant since Nexplanon (etonogestrel) can have androgenic effects contributing to acne 2

Step 2: Assess Response at 8-12 Weeks

If inadequate improvement with topical therapy alone:

Step 3: Consider Systemic Therapy

Option A: Combined Oral Contraceptive (COC) - Preferred hormonal alternative

  • Conditional recommendation from 2024 AAD guidelines 1
  • Multiple formulations are effective: those containing norgestimate, drospirenone, norethindrone acetate, or cyproterone acetate 3
  • Key consideration: The patient is already using Nexplanon for contraception. Discuss whether switching from Nexplanon to a COC is acceptable
    • If contraception is the priority and patient wants to keep Nexplanon, COCs can be added for acne treatment (though this provides redundant contraception)
    • If patient is willing to switch contraceptive methods, transition to a COC that treats both acne and provides contraception 4, 3

Option B: Oral Isotretinoin - Most definitive option

  • Strongly recommended for severe acne, acne causing psychosocial burden or scarring, or acne failing standard therapy 1
  • Critical point: Do not default to oral antibiotics as a bridge therapy
    • The 2024 guidelines emphasize limiting systemic antibiotic use 1
    • Antibiotics require concomitant benzoyl peroxide and should be time-limited
  • Isotretinoin dosing: Traditional daily dosing preferred over intermittent dosing 1
  • Monitoring: Only liver function tests and lipids needed; CBC not required in healthy patients 1
  • Mandatory pregnancy prevention for those of childbearing potential 1

Option C: Short-course Oral Antibiotics - Use sparingly

  • If isotretinoin is not appropriate and COC is declined/contraindicated:
    • Doxycycline (strong recommendation) or minocycline (conditional recommendation) 1
    • Must be combined with benzoyl peroxide to prevent resistance 1
    • Limit duration to reduce antibiotic-associated complications 1
    • This is a temporizing measure, not a long-term solution

Step 4: Adjunctive Measures

  • Intralesional corticosteroids for larger papules/nodules at risk of scarring 1
  • Dietary counseling: Screen for whey protein supplement use and recommend discontinuation if present 5

Critical Pitfalls to Avoid

  1. Do not use topical antibiotics as monotherapy - always combine with benzoyl peroxide 1

  2. Do not prescribe prolonged oral antibiotics - this is the most common error in acne management and contributes to resistance 5

  3. Do not delay isotretinoin in patients with:

    • Severe acne at presentation
    • Psychosocial burden or scarring
    • Failed response to adequate topical therapy trial 1
  4. Do not routinely monitor potassium if considering future spironolactone use - only needed in patients with renal disease, cardiac disease, or medications affecting potassium 1, 5

Why This Approach for Nexplanon-Associated Acne

Nexplanon contains etonogestrel, a progestin-only contraceptive that can have androgenic effects contributing to acne 2. Since spironolactone (the typical anti-androgen for acne) is not tolerated, your options are:

  1. Topical anti-androgens (clascoterone) - addresses local androgen receptor activity
  2. COCs - suppress ovarian androgen production and increase SHBG, reducing free testosterone 4, 3, 6
  3. Isotretinoin - most effective systemic option that bypasses hormonal mechanisms entirely

The evidence strongly supports moving to isotretinoin rather than prolonged antibiotic use if topical therapy fails, especially given the 2024 guidelines' emphasis on antibiotic stewardship 1, 5.

References

Guideline

guidelines of care for the management of acne vulgaris.

Journal of the American Academy of Dermatology, 2024

Research

Combined oral contraceptive pills for treatment of acne.

The Cochrane database of systematic reviews, 2012

Research

A Review of hormone-based therapies to treat adult acne vulgaris in women.

International journal of women's dermatology, 2017

Research

Oral contraceptives as anti-androgenic treatment of acne.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2002

Related Questions

What alternative treatments are available for adult hormonal acne in a patient who cannot use isotretinoin (Accutane) due to side effects?
What additional therapies should be considered for a 20-year-old female patient with recurrent acne who has had limited response to two courses of isotretinoin (Roaccutane) and doxycycline, has normal testosterone levels, and prefers to avoid further isotretinoin?
In a 35-year-old woman with acne who is using topical tretinoin four times weekly, benzoyl peroxide once weekly, and alpha arbutin on non‑tretinoin days, and who will start oral isotretinoin 20 mg daily for six months, should the topical regimen be adjusted?
Can spironolactone (100 mg daily) used for acne cause uterine fibroids or menstrual irregularities?
Can spironolactone cause vaginal dryness in women?
My HSV serology shows positive IgG for HSV‑1 (10.9) and HSV‑2 (1.53) and an indeterminate IgM for HSV‑2 pending; what does this indicate and how should I manage it?
In an 87-year-old patient with pneumonia who has a paronychia not responding to Augmentin (amoxicillin‑clavulanate), what additional treatment should be prescribed?
How frequently do tapeworms autoinfect and disseminate to the bloodstream or tissues such as the brain or eyes?
What is Charcot-Marie-Tooth disease?
Should metformin be held before a shoulder surgery scheduled in 48 hours?
What are the next steps in managing a 12-year-old female with ADHD and possible autism (awaiting assessment) who is currently taking Concerta (methylphenidate) 18 mg extended‑release in the morning, methylphenidate 5 mg in the afternoon, and guanfacine 2 mg extended‑release at bedtime, and now reports that the medications are ineffective, feels overwhelmed, wants to stop the medicines, and is falling behind academically?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.